A61K 38/202
Il-3
Official title: {il-3}
A61K38/202 (Il-3) appears on 75 US grants and 105 published applications in this corpus.
Search patents in A61K- Granted patents
- 75
- Published applications
- 105
- Assignees
- 70
- Inventors
- 178
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 1 |
| 2002 | 4 | 6 |
| 2003 | 3 | 10 |
| 2004 | 1 | 5 |
| 2005 | 1 | 4 |
| 2006 | 3 | 3 |
| 2007 | 3 | 2 |
| 2008 | 2 | 3 |
| 2009 | 0 | 4 |
| 2010 | 5 | 8 |
| 2011 | 1 | 2 |
| 2012 | 2 | 6 |
| 2013 | 4 | 5 |
| 2014 | 4 | 4 |
| 2015 | 9 | 11 |
| 2016 | 3 | 3 |
| 2017 | 3 | 1 |
| 2018 | 0 | 2 |
| 2019 | 1 | 3 |
| 2020 | 1 | 2 |
| 2021 | 2 | 2 |
| 2022 | 1 | 6 |
| 2023 | 1 | 4 |
| 2024 | 2 | 4 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treating an autoimmune disease with a human interleukin-3 (IL-3)-diphtheria toxin conjugate (DT-IL3)14 Jul 2026US 12,678,485 B2Stemline Therapeautics, Inc.
- Combination therapy method of treating myeloproliferative neoplasms with a diphtheria toxin-human interleukin-3 conjugate in combination with other agents15 Jul 2025US 12,357,700 B2Stemline Therapeutics, Inc.
- Methods and compositions based on diphtheria toxin-interleukin-3 conjugates31 Dec 2024US 12,180,257 B2Scott & White Memorial Hospital
- Lyophilized formulation24 Dec 2024US 12,171,800 B2Sterline Therapeutics, Inc.
- Compositions and methods of cellular immunotherapy7 Mar 2023US 11,596,653 B2Crage Medical Co., Limited
- Anti-cancer tgfb2 agents with immunotherapeutics11 Jun 2026US 2026/0159838 A1Gmp Biotechnology Limited
- Anti-cancer tgfb2 agents with immunotherapeutics21 May 2026US 2026/0139253 A1Gmp Biotechnology Limited
- Method of treatment of philadelphia chromosome positive leukemia17 Apr 2025US 2025/0122295 A1CSL Limited
- Improved Lyophilized Formulation20 Feb 2025US 2025/0057915 A1Stemline Therapeutics, Inc.
- Compositions and methods of cellular immunotherapy15 Aug 2024US 2024/0269175 A1Crage Medical Co., Limited
Most cited
By later US patents
- Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors83US 6,270,781 B1Maxim Pharmaceuticals, Inc. · 2001
- Method for purifying granulocyte colony stimulating factor36US 5,849,883 AAmgen Inc. · 1998
- Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides31US 6,248,319 B12001
- Megakaryocyte production27US 5,762,920 AAmgen Inc. · 1998
- Mobilization of hematopoietic stem cells26US 8,383,124 B2Children's Hospital Medical Center · 2013